Genvor Inc

$ Overview Financials Valuation SEC Filings Company Website

2022 Q3 Form 10-Q Financial Statement

#000147793222006078 Filed on August 15, 2022

Income Statement

Concept	2022 Q3	2022 Q2	2021 Q3

Balance Sheet

Concept	2022 Q3	2022 Q2	2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents	$296.4K	$435.4K	$0.00
Short-Term Investments
Other Short-Term Assets	$2.000K
YoY Change
Inventory
Prepaid Expenses	$0.00	$0.00	$3.393K
Receivables
Other Receivables
Total Short-Term Assets	$298.4K	$435.4K	$225.7K
YoY Change	32.2%
LONG-TERM ASSETS
Property, Plant & Equipment	$17.57K	$18.02K	$19.40K
YoY Change	-9.44%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$17.57K	$20.02K	$21.40K
YoY Change	-17.9%
TOTAL ASSETS
Total Short-Term Assets	$298.4K	$435.4K	$225.7K
Total Long-Term Assets	$17.57K	$20.02K	$21.40K
Total Assets	$316.0K	$455.4K	$247.1K
YoY Change	27.86%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$516.7K	$14.36K	$33.32K
YoY Change	1450.64%		344.25%
Accrued Expenses		$34.97K	$122.2K
YoY Change			1936.27%
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$1.868M	$1.553M	$2.248M
YoY Change	-16.92%	40273.19%	12860.08%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$89.22K
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.868M	$1.553M	$2.248M
Total Long-Term Liabilities	$89.22K
Total Liabilities	$1.957M	$1.865M	$2.738M
YoY Change	-28.53%
SHAREHOLDERS EQUITY
Retained Earnings	-$16.29M	-$15.78M	-$11.31M
YoY Change	44.06%	38645.73%
Common Stock	$38.68K	$285.00	$24.51K
YoY Change	57.83%	-98.58%	-78.66%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$1.641M	-$1.410M	-$2.491M
YoY Change
Total Liabilities & Shareholders Equity	$316.0K	$455.4K	$247.1K
YoY Change	27.86%

Cashflow Statement

Concept	2022 Q3	2022 Q2	2021 Q3

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Central Index Key EntityCentralIndexKey	0001792941
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--09-30
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2021Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2021Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2021Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2021Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	24005888	shares
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	37283555	shares
CY2021Q2	us-gaap	Common Stock No Par Value CommonStockNoParValue	0.001
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2021Q3	us-gaap	Assets Held In Trust AssetsHeldInTrust	19705	usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-06-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	333-234815
	dei	Entity Registrant Name EntityRegistrantName	GENVOR INCORPORATED
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	83-2054746
	dei	Entity Address Address Line1 EntityAddressAddressLine1	13155 Noel Road
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 900
	dei	Entity Address City Or Town EntityAddressCityOrTown	Dallas
	dei	Entity Address State Or Province EntityAddressStateOrProvince	TX
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	75240
	dei	City Area Code CityAreaCode	214
	dei	Local Phone Number LocalPhoneNumber	427-1921
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	true
	dei	Entity Shell Company EntityShellCompany	true
CY2022Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	38270067	shares
CY2022Q2	us-gaap	Cash Cash	435388	usd
CY2021Q3	us-gaap	Cash Cash	72315	usd
CY2022Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	0	usd
CY2021Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	3393	usd
CY2022Q2	allure	Prepaid Costs For Reverse Capitalization PrepaidCostsForReverseCapitalization	0	usd
CY2021Q3	allure	Prepaid Costs For Reverse Capitalization PrepaidCostsForReverseCapitalization	150000	usd
CY2022Q2	us-gaap	Assets Current AssetsCurrent	435388	usd
CY2021Q3	us-gaap	Assets Current AssetsCurrent	225708	usd
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	18023	usd
CY2021Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	19397	usd
CY2022Q2	us-gaap	Notes Receivable Related Parties NotesReceivableRelatedParties	2000	usd
CY2021Q3	us-gaap	Notes Receivable Related Parties NotesReceivableRelatedParties	2000	usd
CY2022Q2	us-gaap	Assets Assets	455411	usd
CY2021Q3	us-gaap	Assets Assets	247105	usd
CY2022Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	14356	usd
CY2021Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	33319	usd
CY2022Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	34972	usd
CY2021Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	122176	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	52284	usd
CY2022Q2	us-gaap	Operating Expenses OperatingExpenses	645503	usd
CY2021Q2	us-gaap	Operating Expenses OperatingExpenses	565221	usd
	us-gaap	Operating Expenses OperatingExpenses	4300762	usd
CY2022Q2	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	194929	usd
CY2021Q3	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	388534	usd
CY2022Q2	allure	Usda Crada Liability UsdaCradaLiability	246400	usd
CY2021Q3	allure	Usda Crada Liability UsdaCradaLiability	243600	usd
CY2022Q2	allure	Commercial Loan CommercialLoan	48750	usd
CY2021Q3	allure	Commercial Loan CommercialLoan	48750	usd
CY2022Q2	allure	Short Term Notes Payable Net Of Discount ShortTermNotesPayableNetOfDiscount	0	usd
CY2021Q3	allure	Short Term Notes Payable Net Of Discount ShortTermNotesPayableNetOfDiscount	17500	usd
CY2022Q2	us-gaap	Notes Payable Current NotesPayableCurrent	1009500	usd
CY2021Q3	us-gaap	Notes Payable Current NotesPayableCurrent	1403500	usd
CY2022Q2	allure	Due From To Related Party Shareholders DueFromToRelatedPartyShareholders	3846	usd
CY2021Q3	allure	Due From To Related Party Shareholders DueFromToRelatedPartyShareholders	8176	usd
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	1552753	usd
CY2021Q3	us-gaap	Liabilities Current LiabilitiesCurrent	2248055	usd
CY2022Q2	allure	Long Term Notes Payable Net Of Discount LongTermNotesPayableNetOfDiscount	0	usd
CY2021Q3	allure	Long Term Notes Payable Net Of Discount LongTermNotesPayableNetOfDiscount	10208	usd
CY2022Q2	us-gaap	Long Term Notes Payable LongTermNotesPayable	12500	usd
CY2021Q3	us-gaap	Long Term Notes Payable LongTermNotesPayable	489792	usd
CY2022Q2	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	300000	usd
CY2021Q3	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	0	usd
CY2022Q2	us-gaap	Liabilities Liabilities	1865253	usd
CY2021Q3	us-gaap	Liabilities Liabilities	2737847	usd
CY2022Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2022Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2021Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	37283555	shares
CY2021Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	24005888	shares
CY2021Q3	us-gaap	Common Stock Value CommonStockValue	24506	usd
CY2021Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	8791459	usd
CY2021Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-11306707	usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	-2490742	usd
CY2021Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	247105	usd
CY2021Q2	us-gaap	Revenues Revenues	0	usd
	us-gaap	Revenues Revenues	0	usd
	us-gaap	Revenues Revenues	0	usd
CY2022Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	59958	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	143072	usd
CY2022Q2	allure	Contract Payroll ContractPayroll	37500	usd
CY2021Q2	allure	Contract Payroll ContractPayroll	97500	usd
	allure	Contract Payroll ContractPayroll	180725	usd
	allure	Contract Payroll ContractPayroll	272500	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	3712500	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	7483913	usd
CY2022Q2	us-gaap	Professional Fees ProfessionalFees	45170	usd
CY2021Q2	us-gaap	Professional Fees ProfessionalFees	14319	usd
	us-gaap	Professional Fees ProfessionalFees	132928	usd
	us-gaap	Professional Fees ProfessionalFees	81217	usd
CY2022Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	0	usd
CY2021Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	0	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	109248	usd
	us-gaap	Operating Expenses OperatingExpenses	8032986	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-645503	usd
CY2021Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-565221	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-4300762	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-8032986	usd
CY2022Q2	allure	Gains Losses On Extinguishment Of Debts GainsLossesOnExtinguishmentOfDebts	0	usd
CY2021Q2	allure	Gains Losses On Extinguishment Of Debts GainsLossesOnExtinguishmentOfDebts	0	usd
	allure	Gains Losses On Extinguishment Of Debts GainsLossesOnExtinguishmentOfDebts	-5000	usd
	allure	Gains Losses On Extinguishment Of Debts GainsLossesOnExtinguishmentOfDebts	0	usd
CY2022Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-12240	usd
CY2021Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-22165	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-73242	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-64778	usd
CY2022Q2	allure	Late Fee LateFee	-30000	usd
CY2021Q2	allure	Late Fee LateFee	-30000	usd
	allure	Late Fee LateFee	-90000	usd
	allure	Late Fee LateFee	-90000	usd
CY2022Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-42240	usd
CY2021Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-52165	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-168242	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-154778	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-687743	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-617386	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4469004	usd
	us-gaap	Net Income Loss NetIncomeLoss	-8187764	usd
CY2022Q2	allure	Basic And Diluted Net Loss Per Common Share BasicAndDilutedNetLossPerCommonShare	-0.02
CY2021Q2	allure	Basic And Diluted Net Loss Per Common Share BasicAndDilutedNetLossPerCommonShare	-0.03
	allure	Basic And Diluted Net Loss Per Common Share BasicAndDilutedNetLossPerCommonShare	-0.15
	allure	Basic And Diluted Net Loss Per Common Share BasicAndDilutedNetLossPerCommonShare	-0.40
CY2022Q2	allure	Basic And Diluted Weighted Average Common Shares Outstanding BasicAndDilutedWeightedAverageCommonSharesOutstanding	36439887	shares
CY2021Q2	allure	Basic And Diluted Weighted Average Common Shares Outstanding BasicAndDilutedWeightedAverageCommonSharesOutstanding	24082811	shares
	allure	Basic And Diluted Weighted Average Common Shares Outstanding BasicAndDilutedWeightedAverageCommonSharesOutstanding	30506420	shares
	allure	Basic And Diluted Weighted Average Common Shares Outstanding BasicAndDilutedWeightedAverageCommonSharesOutstanding	20703837	shares
CY2020Q3	us-gaap	Stockholders Equity StockholdersEquity	-17346	usd
	allure	Retroactive Application Of Recapitalization Amount RetroactiveApplicationOfRecapitalizationAmount	-1298328	usd
	allure	Adjusted Balance Beginning Of Period Amount AdjustedBalanceBeginningOfPeriodAmount	-1315674	usd
	allure	Accrued Expenses Paid By Shareholder AccruedExpensesPaidByShareholder	13500	usd
	allure	Founder Shares Issued Amount FounderSharesIssuedAmount	5560567	usd
	allure	Stock Issued For Services Amount StockIssuedForServicesAmount	1323388	usd
	allure	Options Issued For Services OptionsIssuedForServices	599958	usd
	us-gaap	Net Income Loss NetIncomeLoss	-8187764	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	-2006025	usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	-2490742	usd
	allure	Stock Issued For Services Amount StockIssuedForServicesAmount	3840750	usd
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	0	usd
	allure	Stock Issued For Cash Amount StockIssuedForCashAmount	735005	usd
	allure	Stock Issued For Debt Conversion Amount StockIssuedForDebtConversionAmount	1124149	usd
	allure	Payment For Reverses Capitalization PaymentForReversesCapitalization	-150000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4469004	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	-1409842	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4469004	usd
	us-gaap	Net Income Loss NetIncomeLoss	-8187764	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1374	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1374	usd
	allure	Operating Expenses Paid By Shareholder OperatingExpensesPaidByShareholder	0	usd
	allure	Operating Expenses Paid By Shareholder OperatingExpensesPaidByShareholder	13500	usd
	us-gaap	Interest Expense InterestExpense	0	usd
	us-gaap	Interest Expense InterestExpense	10000	usd
	allure	Late Fee Capitalized Into Notes Payable LateFeeCapitalizedIntoNotesPayable	90000	usd
	allure	Late Fee Capitalized Into Notes Payable LateFeeCapitalizedIntoNotesPayable	90000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-5000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	3712500	usd
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	7483913	usd
	allure	Common Stock Issued For Interest Expense CommonStockIssuedForInterestExpense	2500	usd
	allure	Common Stock Issued For Interest Expense CommonStockIssuedForInterestExpense	0	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	10911	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	2916	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-3393	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	7500	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-18963	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	0	usd
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	59742	usd
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	72347	usd
	allure	Increase Decrease In Accrued Payroll IncreaseDecreaseInAccruedPayroll	-67855	usd
	allure	Increase Decrease In Accrued Payroll IncreaseDecreaseInAccruedPayroll	170709	usd
	allure	Increase Decrease In Usda Crada Liability IncreaseDecreaseInUsdaCradaLiability	2800	usd
	allure	Increase Decrease In Usda Crada Liability IncreaseDecreaseInUsdaCradaLiability	-47200	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-667602	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-397705	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	0	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1700	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	0	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1700	usd
	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	735005	usd
	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	0	usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	300000	usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	0	usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	4330	usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	0	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	0	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	500000	usd
	allure	Payment For Reverse Capitalization PaymentForReverseCapitalization	0	usd
	allure	Payment For Reverse Capitalization PaymentForReverseCapitalization	140000	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	0	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	2500	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1030675	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	357500	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	363073	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-41905	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	72315	usd
CY2020Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	103541	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	435388	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	61636	usd
	us-gaap	Interest Paid InterestPaid	0	usd
	us-gaap	Interest Paid InterestPaid	0	usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	usd
	allure	Capital Contribution From Shareholder To Pay Accrued Expenses Note7 CapitalContributionFromShareholderToPayAccruedExpensesNote7	0	usd
	allure	Capital Contribution From Shareholder To Pay Accrued Expenses Note7 CapitalContributionFromShareholderToPayAccruedExpensesNote7	13500	usd
	allure	Principal And Interest Settled Through Common Stock Issuance PrincipalAndInterestSettledThroughCommonStockIssuance	1135946	usd
	allure	Principal And Interest Settled Through Common Stock Issuance PrincipalAndInterestSettledThroughCommonStockIssuance	0	usd
	allure	Accrued Payroll Settled Through Common Stock Issuance AccruedPayrollSettledThroughCommonStockIssuance	125750	usd
	allure	Accrued Payroll Settled Through Common Stock Issuance AccruedPayrollSettledThroughCommonStockIssuance	0	usd
	allure	Discount On Note Payable DiscountOnNotePayable	0	usd
	allure	Discount On Note Payable DiscountOnNotePayable	35000	usd
	allure	Right Of Use Asset Lease Asset And Liability RightOfUseAssetLeaseAssetAndLiability	0	usd
	allure	Right Of Use Asset Lease Asset And Liability RightOfUseAssetLeaseAssetAndLiability	15165	usd
	allure	Prepaid Costs For Reverse Capitalization Recognized In Additional Paid In Capital PrepaidCostsForReverseCapitalizationRecognizedInAdditionalPaidInCapital	150000	usd
	allure	Prepaid Costs For Reverse Capitalization Recognized In Additional Paid In Capital PrepaidCostsForReverseCapitalizationRecognizedInAdditionalPaidInCapital	0	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-15775711	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4469004	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-667602	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p>
	allure	Cash Flow Reportingpolicytextblock CashFlowReportingpolicytextblock	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company follows Accounting Standards Codification (“ASC 230”), <em>Statement of Cash Flows</em>, for cash flow reporting, classifies cash receipts and payments according to whether they stem from operating, investing, or financing activities and provides definitions of each category, and uses the indirect or reconciliation method (“indirect method”) as defined by ASC 230, Statement of Cash Flows, to report net cash flow from operating activities by adjusting net income to reconcile it to net cash flow from operating activities by removing the effects of (a) all deferrals of past operating cash receipts and payments and all accruals of expected future operating cash receipts and payments and (b) all items that are included in net income that do not affect operating cash receipts and payments.</p>
CY2022Q2	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	185388	usd
CY2021Q3	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	usd
	allure	Financial Instrumentspolicytextblock FinancialInstrumentspolicytextblock	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company’s financial instruments include cash and cash equivalents, payables, and accrued interest and short-term and long-term notes payable and are accounted for under the provisions of ASC 825, <em>Financial Instruments</em>. The carrying amount of these financial instruments, as reflected in the accompanying consolidated balance sheet, approximates fair value.</p>
	allure	Fixed Assetspolicytextblock FixedAssetspolicytextblock	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Furniture and equipment are stated at cost. Depreciation is provided by the straight-line method over the useful lives of the related assets, approximately seven years. Expenditures for minor enhancements and maintenance are expensed as incurred.</p>
	allure	Schedule Of Loss Income Per Share Of Common Stocktabletextblock ScheduleOfLossIncomePerShareOfCommonStocktabletextblock	<table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;margin-left:auto;margin-right:auto;width:85%"><tbody><tr style="height:15px"><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong><span style="text-decoration:underline">Instrument</span></strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2022</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2021</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Convertible debt</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,060,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,887,923</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Options</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">10,000</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">1,410,000</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">1,070,000</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">3,297,923</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table>
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1070000	shares
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3297923	shares
CY2022Q2	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	1322000	usd
	us-gaap	Debt Conversion Converted Instrument Shares Issued1 DebtConversionConvertedInstrumentSharesIssued1	1060000	shares
CY2022Q2	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	989000	usd
CY2022Q2	us-gaap	Interest Payable Current InterestPayableCurrent	146946	usd
	us-gaap	Conversion Of Stock Shares Converted1 ConversionOfStockSharesConverted1	2316147	shares
	allure	Loss On Debt Settelment LossOnDebtSettelment	5000	usd
	allure	Schedule Of Future Maturities Of The Notes Payabletabletextblock ScheduleOfFutureMaturitiesOfTheNotesPayabletabletextblock	<table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;margin-left:auto;margin-right:auto;width:85%"><tbody><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">2023</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">12,500</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">2024</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">300,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table>
CY2022Q2	allure	Future Maturities Of Notes Payable Year One FutureMaturitiesOfNotesPayableYearOne	12500	usd
CY2022Q2	allure	Future Maturities Of Notes Payable Year Two FutureMaturitiesOfNotesPayableYearTwo	300000	usd
	us-gaap	Interest Expense Debt InterestExpenseDebt	73242	usd
	us-gaap	Interest Expense Debt InterestExpenseDebt	64778	usd
	allure	Late Fees LateFees	90000	usd
	allure	Late Fees LateFees	90000	usd
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2022Q2	us-gaap	Common Stock No Par Value CommonStockNoParValue	0.001
CY2020Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	230000	shares
CY2020Q3	us-gaap	Common Stock Value CommonStockValue	114828	usd
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	569	shares
CY2022Q2	us-gaap	Common Stock No Par Value CommonStockNoParValue	0.50
CY2022Q2	us-gaap	Common Stock Value CommonStockValue	285	usd
CY2022Q2	allure	Common Stock Shares Cancelled CommonStockSharesCancelled	18144112	shares
CY2022Q2	allure	Common Stock Shares Retaining CommonStockSharesRetaining	1855888	shares
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2022Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	3280000	usd
CY2021Q3	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	2343000	usd
	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210	pure
	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210	pure
	us-gaap	Effective Income Tax Rate Reconciliation Prior Year Income Taxes EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes	0.026	pure
	us-gaap	Effective Income Tax Rate Reconciliation Prior Year Income Taxes EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes	-0.030	pure
	allure	Effective Income Tax Rate Reconciliation Permanent Differences Percent EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent	-0.172	pure
	allure	Effective Income Tax Rate Reconciliation Permanent Differences Percent EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent	-0.071	pure
	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.064	pure
	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.109	pure
	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0.000	pure
	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0.000	pure
CY2022Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	3280000	usd
CY2021Q3	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	2343000	usd
CY2022Q2	allure	Deferred Tax Asset Temporary Differences DeferredTaxAssetTemporaryDifferences	18000	usd
CY2021Q3	allure	Deferred Tax Asset Temporary Differences DeferredTaxAssetTemporaryDifferences	-62000	usd
CY2022Q2	allure	Deferred Tax Asset Permanent Differences DeferredTaxAssetPermanentDifferences	-118000	usd
CY2021Q3	allure	Deferred Tax Asset Permanent Differences DeferredTaxAssetPermanentDifferences	-585000	usd
CY2022Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	3180000	usd
CY2021Q3	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	1696000	usd
CY2022Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	usd
CY2021Q3	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	usd
	us-gaap	Valuation Allowances And Reserves Period Increase Decrease ValuationAllowancesAndReservesPeriodIncreaseDecrease	1484000	usd
	us-gaap	Valuation Allowances And Reserves Period Increase Decrease ValuationAllowancesAndReservesPeriodIncreaseDecrease	1952000	usd
CY2022Q2	us-gaap	Assets Held In Trust AssetsHeldInTrust	19705	usd
CY2021Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1073388	usd
CY2021	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	2810	usd
	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	30574	usd
	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	20094	usd
	allure	Merger With Old Genvordisclosuretextblock MergerWithOldGenvordisclosuretextblock	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><span style="text-decoration:underline">NOTE 8 – MERGER WITH OLD GENVOR</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On May 27, 2022, the Company, formerly known as Allure Worldwide, Inc., Merger Sub, and Old Genvor completed the Acquisition and Merger transaction (Note 1). The transaction was completed pursuant to the Merger Agreement, pursuant to which Merger Sub merged with and into Old Genvor, with Old Genvor continuing as a wholly owned subsidiary of the Company and the surviving corporation in the Merger. Immediately upon completion of the Merger, the former stockholders of Old Genvor stockholders held a majority of the common stock and voting interest of the combined company.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In the Merger, the Company issued shares of its common stock to Old Genvor stockholders at an exchange ratio of 1:1 (with each share of Old Genvor common stock automatically converted in the merger into the right to receive a share of Company common stock, and a total of 35,261,871 shares of Company common stock issued to Old Genvor’s pre-merger stockholders). Pursuant to the original Acquisition agreement and Merger, the Company’s founding shareholders retained 5% of the Company’s outstanding shares of common stock, or 1,855,888 shares (Note 4). After closing the Acquisition and for a period of two years following commencement of trading of the Company’s common stock, the Company and Old Genvor agreed that the Company will make additional issuances of the Company’s common stock to the founding shareholders to ensure that in the aggregate they maintain their 5% ownership of the Company’s outstanding common stock. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Pursuant to business combination accounting for reverse acquisitions, the Company accounted for the Merger as a capital transaction (reverse recapitalization) rather than a business combination (or asset acquisition). Since the Company was formerly a special purpose acquisition company (SPAC) with no assets and only expenses related to maintaining its public shell company status, and Old Genvor has cash, other assets, a contract with the USDA (Note 6), and has raised funds from investors, Old Genvor was determined to be the accounting acquirer. Because a reverse recapitalization is equivalent to the issuance of shares by the private operating company for the net monetary assets of the public shell company, the transaction costs incurred by Old Genvor to effect the recapitalization were recognized as a reduction in additional paid-in capital rather than expensed as incurred. The assets and liabilities of Old Genvor were consolidated with the Company at their book value, the equity accounts were retroactively adjusted to reflect the equity of the Company, with a balancing adjustment through the additional paid-in capital account.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">During the nine months ended September 30, 2021 and 2020, the Company paid $140,000 and $10,000, respectively, in anticipation of closing the Acquisition. The total $150,000 was recognized in additional paid-in capital as of the date of the Merger.</p>
CY2022Q2	us-gaap	Common Stock Value CommonStockValue	37284	usd
CY2022Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	14328585	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-15775711	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	-1409842	usd
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	455411	usd
CY2022Q2	us-gaap	Revenues Revenues	0	usd
CY2021Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	53417	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	165361	usd

Files In Submission

Name	View Source	Status
0001477932-22-006078-index-headers.html	Edgar Link	pending
0001477932-22-006078-index.html	Edgar Link	pending
0001477932-22-006078.txt	Edgar Link	pending
0001477932-22-006078-xbrl.zip	Edgar Link	pending
allure-20220630.xsd	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
genvor_10q.htm	Edgar Link	pending
genvor_ex311.htm	Edgar Link	pending
genvor_ex321.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
allure-20220630_def.xml	Edgar Link	unprocessable
allure-20220630_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
allure-20220630_cal.xml	Edgar Link	unprocessable
genvor_10q_htm.xml	Edgar Link	completed
allure-20220630_lab.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

Genvor Inc

2022 Q3 Form 10-Q Financial Statement

#000147793222006078 Filed on August 15, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission